Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry.
Selvarajah A, Tavenier AH, Bor WL, Houben V, Rasoul S, Kaplan E, Teeuwen K, Hofma SH, Lipsic E, Amoroso G, van Leeuwen MAH, Ten Berg JM, van 't Hof AWJ, Hermanides RS. Selvarajah A, et al. Among authors: teeuwen k. Eur Heart J Open. 2021 Oct 18;1(3):oeab028. doi: 10.1093/ehjopen/oeab028. eCollection 2021 Nov. Eur Heart J Open. 2021. PMID: 35923807 Free PMC article. No abstract available.
Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial.
Yeh RW, Bertrand OF, Mahmud E, Barbato E, Falah B, Issever MO, Redfors B, Popma A, Curtis M, van Royen N, Tanguay JF, Janssens L, Newman WN, Teeuwen K, Choi JW, Dirksen MT, Maehara A, Leon MB. Yeh RW, et al. Among authors: teeuwen k. J Am Coll Cardiol. 2025 Feb 18;85(6):563-574. doi: 10.1016/j.jacc.2024.10.074. Epub 2024 Oct 30. J Am Coll Cardiol. 2025. PMID: 39480379 Clinical Trial.
Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial.
Zivelonghi C, van Andel M, Venturi G, Amoroso G, Teeuwen K, Tijssen JGP, Tavella D, Ribichini F, Ten Berg JM, Resning BJ, Henriques JPS, Suttorp MJ, Agostoni P, Van der Schaaf RJ. Zivelonghi C, et al. Among authors: teeuwen k. Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E81-E89. doi: 10.1002/ccd.27795. Epub 2018 Oct 2. Catheter Cardiovasc Interv. 2019. PMID: 30280464 Clinical Trial.
Complex Large-Bore Radial percutaneous coronary intervention: rationale of the COLOR trial study protocol.
Meijers TA, Aminian A, Teeuwen K, van Wely M, Schmitz T, Dirksen MT, van der Schaaf RJ, Iglesias JF, Agostoni P, Dens J, Knaapen P, Rathore S, Ottervanger JP, Dambrink JE, Roolvink V, Gosselink ATM, Hermanides RS, van Royen N, van Leeuwen MAH. Meijers TA, et al. Among authors: teeuwen k. BMJ Open. 2020 Jul 20;10(7):e038042. doi: 10.1136/bmjopen-2020-038042. BMJ Open. 2020. PMID: 32690749 Free PMC article.
Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention.
Meijers TA, Aminian A, van Wely M, Teeuwen K, Schmitz T, Dirksen MT, Rathore S, van der Schaaf RJ, Knaapen P, Dens J, Iglesias JF, Agostoni P, Roolvink V, Hermanides RS, van Royen N, van Leeuwen MAH. Meijers TA, et al. Among authors: teeuwen k. JACC Cardiovasc Interv. 2021 Jun 28;14(12):1293-1303. doi: 10.1016/j.jcin.2021.03.041. Epub 2021 May 18. JACC Cardiovasc Interv. 2021. PMID: 34020929 Free article.
Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry.
Selvarajah A, Tavenier AH, Bor WL, Houben V, Rasoul S, Kaplan E, Teeuwen K, Hofma SH, Lipsic E, Amoroso G, van Leeuwen MAH, Berg JMT, van 't Hof AWJ, Hermanides RS. Selvarajah A, et al. Among authors: teeuwen k. BMC Cardiovasc Disord. 2021 Jun 12;21(1):292. doi: 10.1186/s12872-021-02093-4. BMC Cardiovasc Disord. 2021. PMID: 34118880 Free PMC article.
Extremity Dysfunction After Large-Bore Radial and Femoral Arterial Access.
Meijers TA, Aminian A, van Wely M, Teeuwen K, Schmitz T, Dirksen MT, Rathore S, van der Schaaf RJ, Knaapen P, Dens J, Iglesias JF, Agostoni P, Roolvink V, Lemmert ME, Hermanides RS, van Royen N, van Leeuwen MAH. Meijers TA, et al. Among authors: teeuwen k. J Am Heart Assoc. 2022 Jan 18;11(2):e023691. doi: 10.1161/JAHA.121.023691. Epub 2022 Jan 13. J Am Heart Assoc. 2022. PMID: 35023343 Free PMC article.
Characteristics, Treatment Strategies and Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Contemporary Dutch Cohort.
Peters EJ, Berg ST, Bogerd M, Timmermans MJC, Kraaijeveld AO, Bunge JJH, Teeuwen K, Lipsic E, Sjauw KD, Geuns RMV, Dedic A, Dubois EA, Meuwissen M, Danse P, Verouden NJW, Bleeker G, Cabezas JMM, Ferreira IA, Engström AE, Lagrand WK, Otterspoor LC, Vlaar APJ, Henriques JPS, On Behalf Of The Participating Centers Of The Pci Registration Committee Of The Netherlands Heart Registration. Peters EJ, et al. Among authors: teeuwen k. J Clin Med. 2023 Aug 10;12(16):5221. doi: 10.3390/jcm12165221. J Clin Med. 2023. PMID: 37629263 Free PMC article.
Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
Dillen DMM, Vlaar PJ, Vermeer AJE, Paradies V, van Kuijk JP, Vink MA, Oemrawsingh RM, Hofma SH, Magro M, Remkes WS, de Smet BJGL, van Rees JB, Somi S, Halim J, Zimmermann FM, Wijnbergen IF, Tijssen JGP, Tonino PAL, Teeuwen K. Dillen DMM, et al. Among authors: teeuwen k. Am Heart J. 2023 Dec;266:168-175. doi: 10.1016/j.ahj.2023.09.010. Epub 2023 Oct 6. Am Heart J. 2023. PMID: 37806333 Clinical Trial.
52 results